Related Experiment Video
Updated: Apr 11, 2026

11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.9K
Peripheral blood stem cell mobilization from healthy donors
Melda Comert Ozkan1, Fahri Sahin1, Guray Saydam1
1Department of Hematology, Ege University Medical School, İzmir, Turkey.
Summary
Peripheral blood stem cells (PBSCs) are vital for transplants. Optimizing granulocyte colony-stimulating factor (G-CSF) dosage ensures sufficient PBSC collection while safeguarding donor health.
Area of Science:
- Hematology
- Transplantation Medicine
- Cellular Biology
Background:
- Allogeneic transplantation frequently utilizes peripheral blood stem cells (PBSCs) as the primary graft source.
- Mobilization of PBSCs from healthy donors is typically achieved using granulocyte colony-stimulating factor (G-CSF).
Purpose of the Study:
- To summarize key aspects of PBSC mobilization in healthy donors.
- To review characteristic features, potential side effects, and critical considerations for G-CSF administration.
Main Methods:
- Literature review and synthesis of current knowledge on PBSC mobilization.
- Analysis of G-CSF dosage, efficacy, and donor safety profiles.
Main Results:
- Optimal G-CSF dosing is crucial for adequate PBSC mobilization and harvest.
- Balancing mobilization efficiency with donor health preservation is a primary objective.
- Understanding G-CSF's characteristic effects and potential adverse events is essential.
Conclusions:
- Effective PBSC mobilization requires careful G-CSF administration.
- Prioritizing donor well-being is paramount in allogeneic stem cell donation.
- Further research may refine mobilization protocols for enhanced safety and efficacy.
Related Concept Videos
Bone Marrow Sampling and Transplants
2.6K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.6K
Stem Cell Therapy for Tissue Regeneration
4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Multipotency of Hematopoietic Stem Cells
4.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K

